PDF) P374 Non-alcoholic fatty liver disease in inflammatory bowel disease: Prevalence and risk factors
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - Scientific Programme
European Crohn´s and Colitis Organisation - ECCO - Statistics
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
Collections | Cancer Gene Therapy
Table of Contents page: European Journal of Cancer
European Crohn´s and Colitis Organisation - ECCO - P292 Effect of drug therapy on the lipid profiles of patient with Inflammatory Bowel Disease: a systematic review and meta-analysis
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
European Crohn´s and Colitis Organisation - ECCO - 10th Congress of ECCO, Barcelona 2015
European Crohn´s and Colitis Organisation - ECCO - OP17 Impact of phenotypic and genetic factors on Crohn's Disease evolution in a cohort of 13,926 patients
European Crohn´s and Colitis Organisation - ECCO - 13th Congress of ECCO, Vienna 2018
EULAR 2023 – Abstract archive
European Crohn´s and Colitis Organisation - ECCO - P653 The changing epidemiology of IBD in the western world: a population-based study from Denmark
European Crohn´s and Colitis Organisation - ECCO - Home
All abstracts for the ICOS Science Conference 2020 | ICOS
European Crohn´s and Colitis Organisation - ECCO - 14th Congress of ECCO, Copenhagen 2019
European Crohn´s and Colitis Organisation - ECCO - Statistics
Media Kit 2020 2020
European Crohn´s and Colitis Organisation - ECCO - Home
European Crohn´s and Colitis Organisation - ECCO - ECCO News
European Crohn´s and Colitis Organisation - ECCO - Published ECCO Guidelines
